Challenging a dogma: five-year survival does not equal cure in all colorectal cancer patients

被引:11
作者
Abdel-Rahman, Omar [1 ]
机构
[1] Ain Shams Univ, Dept Clin Oncol, Fac Med, Lotfy Elsayed St, Cairo 11566, Egypt
关键词
Colon cancer; rectal cancer; five years; survival; cure; CLINICAL-PRACTICE GUIDELINES; COLON-CANCER; FOLLOW-UP;
D O I
10.1080/14737140.2018.1409625
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: The current study tried to evaluate the factors affecting 10- to 20- years' survival among long term survivors (>5years) of colorectal cancer (CRC).Methods: Surveillance, Epidemiology and End Results (SEER) database (1988-2008) was queried through SEER*Stat program.Univariate probability of overall and cancer-specific survival was determined and the difference between groups was examined. Multivariate analysis for factors affecting overall and cancer-specific survival was also conducted.Results: Among node positive patients (Dukes C), 34% of the deaths beyond 5 years can be attributed to CRC; while among M1 patients, 63% of the deaths beyond 5 years can be attributed to CRC. The following factors were predictors of better overall survival in multivariate analysis: younger age, white race (versus black race), female gender, Right colon location (versus rectal location), earlier stage and surgery (P <0.0001 for all parameters). Similarly, the following factors were predictors of better cancer-specific survival in multivariate analysis: younger age, white race (versus black race), female gender, Right colon location (versus left colon and rectal locations), earlier stage and surgery (P <0.0001 for all parameters).Conclusion: Among node positive long-term CRC survivors, more than one third of all deaths can be attributed to CRC.
引用
收藏
页码:187 / 192
页数:6
相关论文
共 18 条
[1]  
Abdel-Rahman O, 2017, CLIN TRANSL ONCOL
[2]   Targeting BRAF aberrations in advanced colorectal carcinoma: from bench to bedside [J].
Abdel-Rahman, Omar .
FUTURE ONCOLOGY, 2016, 12 (01) :25-30
[3]   Advances in the management of colorectal cancer: from biology to treatment [J].
Ahmed, Shahid ;
Johnson, Kate ;
Ahmed, Osama ;
Iqbal, Nayyer .
INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2014, 29 (09) :1031-1042
[4]   Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study [J].
Allemani, Claudia ;
Rachet, Bernard ;
Weir, Hannah K. ;
Richardson, Lisa C. ;
Lepage, Come ;
Faivre, Jean ;
Gatta, Gemma ;
Capocaccia, Riccardo ;
Sant, Milena ;
Baili, Paolo ;
Lombardo, Claudio ;
Aareleid, Tiiu ;
Ardanaz, Eva ;
Bielska-Lasota, Magdalena ;
Bolick, Susan ;
Cress, Rosemary ;
Elferink, Marloes ;
Fulton, John P. ;
Galceran, Jaume ;
Gozdz, Stanislaw ;
Hakulinen, Timo ;
Primic-Zakelj, Maja ;
Rachtan, Jadwiga ;
Diba, Chakameh Safaei ;
Sanchez, Maria-Jose ;
Schymura, Maria J. ;
Shen, Tiefu ;
Tagliabue, Giovanna ;
Tumino, Rosario ;
Vercelli, Marina ;
Wolf, Holly J. ;
Wu, Xiao-Cheng ;
Coleman, Michel P. .
BMJ OPEN, 2013, 3 (09)
[5]   The IDEA (International Duration Evaluation of Adjuvant Chemotherapy) Collaboration: Prospective Combined Analysis of Phase III Trials Investigating Duration of Adjuvant Therapy with the FOLFOX (FOLFOX4 or Modified FOLFOX6) or XELOX (3 versus 6 months) Regimen for Patients with Stage III Colon Cancer: Trial Design and Current Status [J].
Andre, Thierry ;
Iveson, Timothy ;
Labianca, Roberto ;
Meyerhardt, Jeffrey A. ;
Souglakos, Ioannis ;
Yoshino, Takayuki ;
Paul, James ;
Sobrero, Alberto ;
Taieb, Julien ;
Shields, Anthony F. ;
Ohtsu, Atsushi ;
Grothey, Axel ;
Sargent, Daniel J. .
CURRENT COLORECTAL CANCER REPORTS, 2013, 9 (03) :261-269
[6]   Colon Cancer, Version 1.2017 Clinical Practice Guidelines in Oncology [J].
Benson, Al B., III ;
Venook, Alan P. ;
Cederquist, Lynette ;
Chan, Emily ;
Chen, Yi-Jen ;
Cooper, Harry S. ;
Deming, Dustin ;
Engstrom, Paul F. ;
Enzinger, Peter C. ;
Fichera, Alessandro ;
Grem, Jean L. ;
Grothey, Axel ;
Hochster, Howard S. ;
Hoffe, Sarah ;
Hunt, Steven ;
Kamel, Ahmed ;
Kirilcuk, Natalie ;
Krishnamurthi, Smitha ;
Messersmith, Wells A. ;
Mulcahy, Mary F. ;
Murphy, James D. ;
Nurkin, Steven ;
Saltz, Leonard ;
Sharma, Sunil ;
Shibata, David ;
Skibber, John M. ;
Sofocleous, Constantinos T. ;
Stoffel, Elena M. ;
Stotsky-Himelfarb, Eden ;
Willett, Christopher G. ;
Wu, Christina S. ;
Gregory, Kristina M. ;
Freedman-Cass, Deborah .
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (03) :370-398
[7]   Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies [J].
Brenner, Hermann ;
Stock, Christian ;
Hoffmeister, Michael .
BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
[8]   Functional Consequences of Colorectal Cancer Management [J].
Fish, Daniel ;
Temple, Larissa K. .
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 23 (01) :127-+
[9]   Proteomic analysis reveals large amounts of decomposition enzymes and major metabolic pathways involved in algicidal process of Trametes versicolor F21a [J].
Gao, Xueyan ;
Wang, Congyan ;
Dai, Wei ;
Ren, Shenrong ;
Tao, Fang ;
He, Xingbing ;
Han, Guomin ;
Wang, Wei .
SCIENTIFIC REPORTS, 2017, 7
[10]   Screening for colorectal cancer using the faecal occult blood test, Hemoccult [J].
Hewitson, P. ;
Glasziou, P. ;
Irwig, L. ;
Towler, B. ;
Watson, E. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01)